CHIEF FINANCIAL OFFICER
Thu, May 23, 2024
May 23
exercised or converted securities in ACLX
22,428 shares @ $0.00
Decreased holdings by -50.00%
Net across this filing: +108.70% (+10,307 shares)
Option Exercise
Sale tied to a same-time option exercise
ACLXArcellx, Inc.
Health CareBiotechnology